03689 KANGHUA HEALTH
- 2.550
- 0.0000.00%
KANGHUA HEALTH News
Kanghua Healthcare (03689.HK) gains 482,800 shares by Mialkos Tomasz Jakub
Glonghui, May 3 | According to the Stock Exchange's latest equity disclosure, on April 26, 2024, Kanghua Healthcare (03689.HK) received Mialkos Tomasz Jakub to increase its holdings by 482,800 shares at an average price of HK$2.10 per share on the market, involving approximately HK$1.013,900. After the increase in holdings, the latest number of shares held by Mialkos Tomasz Jakub was 4.6874 million shares, and the shareholding ratio increased from 4.98% to 5.55%.
Kanghua Healthcare (03689.HK) received 482,800 H shares from Tomasz Jakub Mialkos, worth approximately HK$1,013,900
On April 30, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 30, Tomasz Jakub Mialkos increased its holdings of $Kanghua Healthcare (03689.HK) H shares by 482,800 with an average price of HK$2.1 per share, worth about HK$1,013,900 on April 26. After the increase in holdings, Tomasz Jakub Mialkos's latest shareholding was 4.6874 million shares, and the good position ratio increased from 4.98% to 5.55%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, the majority shareholder
Kanghua Medical (03689) plans to change its name to “Guangdong Kanghua Medical Group Co., Ltd.”
Kanghua Medical (03689) issued an announcement. The board of directors of the company proposed that the company name be Guangdong Kanghua Medical Co., Ltd...
康華醫療：2023 年報
China Post Securities: Endogenous growth is steady, and the Hong Kong stock healthcare services sector's valuation is highly attractive
Judging from the overall performance of medical service targets in Hong Kong stocks, with the exception of ICL's high revenue base in the early COVID-19 period, where dental revenue was affected by dental implant collection, most of the revenue from other medical service targets increased relatively well.
Kanghua Healthcare (03689) announces 2023 annual results. Profit attributable to shareholders of 121 million yuan increased by 102.8% year-on-year
Kanghua Healthcare (03689) announced its annual results for the year ended December 31, 2023. The group made profits during the period...
KANGHUA HEALTH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Kanghua Healthcare (03689.HK) held a board meeting on March 28 to consider and approve the annual results
Glonghui, March 18, 丨 Kanghua Healthcare (03689.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the proposed payment of a final dividend (if any).
Guangdong Kanghua Healthcare Acquires Haemodialysis Operating Company for 7.7 Million Yuan
Guangdong Kanghua Healthcare (HKG:3689) agreed to acquire 70% of Dongguan Kanghua Haemodialysis Healthcare Investment Management from Dongguan YouWang Enterprise Investment for a consideration of 7.7
Kanghua Medical (03689.HK): Plans to acquire 70% of Dongguan Kanghua Hemodialysis Healthcare Investment Management's shares for 7.7 million yuan
On December 15, Gelonghui (03689.HK) announced that on December 15, 2023, the company signed an acquisition agreement. According to this, the company has agreed to acquire 70% of the shares of the target company Dongguan Kanghua Hemodialysis Medical Investment Management Co., Ltd. from the seller at a total cost of RMB 7.7 million. The target company, through its subsidiaries, mainly operates hemodialysis clinic centers in China. Upon completion, the target company will become a non-wholly owned subsidiary of the company. According to reports, the target company is a limited liability company established in China on February 24, 2016. The target company mainly through its subsidiaries
KANGHUA HEALTH: Interim Report 2023
Chen Zhaoming sold 5.7693 million H-shares of Kanghua Healthcare (03689.HK) off-market, worth about HK$8,423,200
On September 12, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on September 12, Chen Zhaoming sold $5.7693 million H shares of Kanghua Healthcare (03689.HK) on September 5 at an average price of HK$1.46 per share, worth about HK$8,423,300. After the sale, the latest number of shares held by Chen Zhaoming was 4,8257 million shares, and the ratio of good positions dropped from 12.55% to 5.72%. Image source: Stock Exchange equity disclosure What is an equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) must disclose their share interests in listed companies.
Kanghua Healthcare (03689) announces interim results, with profit attributable to shareholders of 506.55 million yuan
According to Zhitong Financial App News, Kanghua Medical (03689) announced the results for the six months ended June 30, 2023, with revenue of 987 million yuan (RMB, same below), an increase of 14.5% over the previous year; profit attributable to company owners was 506.55 million yuan, loss of 4771 million yuan in the same period last year; basic profit of 15.1 points per share.
KANGHUA HEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Kanghua Healthcare (03689.HK) will hold a board meeting on August 31 to approve the interim results
Glonghui, August 21丨Kanghua Healthcare (03689.HK) announced that the company will hold a board meeting on August 31, 2023 to consider and approve the company and its subsidiaries' interim results for the six months ended June 30, 2023, and pay interim dividends (if any).
KANGHUA HEALTH: DATE OF BOARD MEETING
Kanghua Healthcare (03689.HK) received an off-market increase of 131,000 H shares by Chan Siu-ming, worth approximately HK$281,700
On May 24, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 24, Chan Siu-ming increased his OTC H-share holdings of Kanghua Healthcare (03689.HK) by $131,000 at an average price of HK$2.15 per share on May 10, worth about HK$281,700. After increasing his holdings, Chen Zhaoming recently held 105.95 million shares, and the good position ratio increased from 12.40% to 12.55%. Additional Information: This is a Completed Filing to Reflect the Purchase of 131,00
Kanghua Healthcare: 2022 Annual Report
Guangdong Kanghua Healthcare's 2022 Attributable Profit Declines
04:04 AM EDT, 04/03/2023 (MT Newswires) -- Guangdong Kanghua Healthcare's (HKG:3689) 2022 attributable profit declined to 61 million yuan, or 0.183 yuan per share, from 94.3 million yuan, or 0.282 yua
Kanghua Healthcare (03689.HK): Adjusted EBITDA reduced by 30% to $216 million in 2022
Gelonghui, March 31, 丨 Kanghua Medical (03689.HK) announced that in 2022, earnings fell 5.5% to RMB 1.85 billion; profit attributable to company owners for the year decreased 35.3% to RMB 61 million, profit per share was RMB 18.3 per share; adjusted EBITDA decreased by 30.0% to RMB 216 million. In 2022, the Group's comprehensive revenue for the year decreased 5.5% year over year. This was mainly due to a 6.4% decrease in hospital service department revenue due to a decrease in the overall number of visits to its own hospital business. Relating to reducing rehabilitation and other medical treatment
Analysis
Price Target
No Data
